# Effects of Probiotics in Amyotrophic Lateral Sclerosis-Frontotemporal Dementia Spectrum Disorder (ALS-FTDSD) Patients

> **NCT06051123** · NA · RECRUITING · sponsor: **Centre hospitalier de l'Université de Montréal (CHUM)** · enrollment: 150 (estimated)

## Conditions studied

- ALSFTD
- ALS (Amyotrophic Lateral Sclerosis)
- Frontal Temporal Dementia (FTD)

## Interventions

- **DIETARY_SUPPLEMENT:** Probiotic
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT06051123
- **Lead sponsor:** Centre hospitalier de l'Université de Montréal (CHUM)
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-01-01
- **Primary completion:** 2027-02
- **Final completion:** 2027-02
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2026-04-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06051123

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06051123, "Effects of Probiotics in Amyotrophic Lateral Sclerosis-Frontotemporal Dementia Spectrum Disorder (ALS-FTDSD) Patients". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT06051123. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*